
立即查看

立即引荐

立即监控
立即查看
立即引荐
立即监控
我院对拟以下采购项目进行采购意向公告,欢迎有意向的供应商进行咨询。
一、 项目基本情况
序号 | 项目名称 | 项目概况 |
1 | 2SC | 1、符合国家资质要求,适用于石蜡组织切片检测; 2.提供的试剂目录数量需含本目录内65%及以上。 |
2 | AACT | |
3 | AAT | |
4 | ACTH | |
5 | Actin | |
6 | ALK(CD245) | |
7 | Alpha-1-Fetoprotein | |
8 | AMACR/p504s | |
9 | APC | |
10 | AR | |
11 | Arginase-1 | |
12 | ATRX | |
13 | B72.3 | |
14 | bcl-2 | |
15 | bcl-6 | |
16 | BCOR | |
17 | Ber-EP4 | |
18 | Beta-catenin | |
19 | Bob.1 | |
20 | Brachyury | |
21 | BRAFV600E | |
22 | BRCA1 | |
23 | C1q | |
24 | C3c | |
25 | C4c | |
26 | C4d | |
27 | CA125 | |
28 | CA15-3 | |
29 | CA19-9 | |
30 | Cadherin17 | |
31 | CAIX | |
32 | Calcitonin | |
33 | Caldesmon | |
34 | Calponin | |
35 | Calretinin | |
36 | CAM5.2 | |
37 | CD10 | |
38 | CD103 | |
39 | CD105 | |
40 | CD117 | |
41 | CD123 | |
42 | CD13 | |
43 | CD138 | |
44 | CD14 | |
45 | CD146 | |
46 | CD15 | |
47 | CD16 | |
48 | CD163 | |
49 | CD19 | |
50 | CD1a | |
51 | CD2 | |
52 | CD20 | |
53 | CD21 | |
54 | CD22 | |
55 | CD23 | |
56 | CD235a, Glycophorin A | |
57 | CD25 | |
58 | CD3 | |
59 | CD30 | |
60 | CD31 | |
61 | CD33 | |
62 | CD34 | |
63 | CD35 | |
64 | CD38 | |
65 | CD4 | |
66 | CD42b | |
67 | CD43 | |
68 | CD44 | |
69 | CD44v6 | |
70 | CD45 | |
71 | CD45RA | |
72 | CD45RO | |
73 | CD47 | |
74 | CD5 | |
75 | CD56 | |
76 | CD57 | |
77 | CD61 | |
78 | CD68 | |
79 | CD7 | |
80 | CD71 | |
81 | CD74 | |
82 | CD79a | |
83 | CD8 | |
84 | CD99 | |
85 | CDK4 | |
86 | CDX-2 | |
87 | CEA | |
88 | Chromogranin | |
89 | CK | |
90 | CK10 13 | |
91 | CK14 | |
92 | CK17 | |
93 | CK18 | |
94 | CK19 | |
95 | CK20 | |
96 | CK(高分子细胞角蛋白34βE12) | |
97 | CK5 6 | |
98 | CK7 | |
99 | CK8 | |
100 | CK8 18 | |
101 | Claudin 1 | |
102 | Claudin 18.2 | |
103 | Claudin 4 | |
104 | c-MYC | |
105 | CollagenTypeIV | |
106 | COX-2 | |
107 | CXCL-13 | |
108 | Cyclin D1 | |
109 | CYP11B1 | |
110 | CYP11B2 | |
111 | Cytomegalovirus | |
112 | D2-40 | |
113 | DDIT3 | |
114 | Desmin | |
115 | DOG1 | |
116 | DPC4 | |
117 | DSG3 | |
118 | DUX4 | |
119 | EBER探针 | |
120 | EBNA-2 | |
121 | EBV | |
122 | E-Cadherin | |
123 | EGFR | |
124 | EMA | |
125 | Ep-CAM | |
126 | ER | |
127 | ERCC1 | |
128 | ERG | |
129 | ESA | |
130 | EZH2 | |
131 | FactorⅧ受体 | |
132 | FactorXIIIA | |
133 | Fascin | |
134 | FGFR3 | |
135 | FH | |
136 | Fibrinogen | |
137 | Fibronectin | |
138 | FLI-1 | |
139 | FoxA1 | |
140 | FOXL2 | |
141 | FOXP1 | |
142 | FoxP3 | |
143 | FRα | |
144 | FSH | |
145 | Galectin-3 | |
146 | Gastrin | |
147 | GATA3 | |
148 | GCDFP-15 | |
149 | GFAP | |
150 | Glucagon | |
151 | GLUT-1 | |
152 | GlutamineSynthetase | |
153 | GlycophorinA | |
154 | Glypican3 | |
155 | GranzymeB | |
156 | GST-π | |
157 | H/K ATPase β | |
158 | H3.3G34W | |
159 | H3K27Me3 | |
160 | H3K36M | |
161 | HBcAg | |
162 | HBsAg | |
163 | hCG-α | |
164 | HE4 | |
165 | Helicobacterphlori | |
166 | Hepatocyte | |
167 | HER-2 | |
168 | HGAL | |
169 | HHV-8 | |
170 | HIF-1α | |
171 | HIK1083 | |
172 | HMB-45 | |
173 | HNF1-Beta | |
174 | HSP70 | |
175 | HumanGrowthHormone | |
176 | HumanPlacentalLactogen | |
177 | ICOS | |
178 | IDH-1 | |
179 | IDO1 | |
180 | IgA | |
181 | IgD | |
182 | IgG | |
183 | IgG1 | |
184 | IgG2 | |
185 | IgG3 | |
186 | IgG4 | |
187 | IgM | |
188 | IMP3 | |
189 | Inhibin,alpha | |
190 | INI1 | |
191 | INSM1 | |
192 | Insulin | |
193 | Kappa链 | |
194 | Ki-67 | |
195 | Ksp-Cadherin | |
196 | Lambda链 | |
197 | Laminin | |
198 | Langerin | |
199 | LEF-1 | |
200 | LH | |
201 | LIN28 | |
202 | LRP | |
203 | Lysozyme | |
204 | Mammaglobin | |
205 | MAP2a.b.c | |
206 | MART-1/melanA | |
207 | MC | |
208 | MCM2 | |
209 | MCT | |
210 | MDM2 | |
211 | MDR-1 | |
212 | Mesothelin | |
213 | MGMT | |
214 | MHA | |
215 | MiTF | |
216 | MMP-9 | |
217 | MNDA | |
218 | MOC-31 | |
219 | MUC-1 | |
220 | MUC2 | |
221 | MUC4 | |
222 | MUC5AC | |
223 | MUC6 | |
224 | MUM1 | |
225 | MyelinBasicProtein | |
226 | Myeloperoxidase | |
227 | MyoD1 | |
228 | Myogenin | |
229 | Myoglobin | |
230 | MyosinHeavyChain | |
231 | NapsinA | |
232 | Nestin | |
233 | NeuN | |
234 | Neurofilament | |
235 | NKX2.2 | |
236 | Nkx3.1 | |
237 | nm23 | |
238 | NOR-1 | |
239 | NSE | |
240 | NUT | |
241 | NY-ESO-1 | |
242 | 45932 | |
243 | Oct3/4 | |
244 | 45934 | |
245 | Oligo-2 | |
246 | p120 | |
247 | p16 | |
248 | p27 | |
249 | p40 | |
250 | p53 | |
251 | p57 | |
252 | p63 | |
253 | PapillomaVirus | |
254 | Pax-2 | |
255 | Pax-5 | |
256 | Pax-8 | |
257 | PC | |
258 | PCNA | |
259 | PD-1 | |
260 | PDGFRα | |
261 | Pepsinogen I | |
262 | Perforin | |
263 | P-Glycoprotein | |
264 | PGP 9.5 | |
265 | PHH3 | |
266 | PHOX2B | |
267 | PIT-1 | |
268 | PLAP | |
269 | PNL2 | |
270 | PR | |
271 | PRAME | |
272 | PRL | |
273 | pS2 | |
274 | PSA | |
275 | PSAP | |
276 | PSMA | |
277 | PTEN | |
278 | PTH | |
279 | PU.1 | |
280 | RbGeneProtein | |
281 | RenalCellCarcinomaMarker | |
282 | ROS1 | |
283 | RRM1 | |
284 | S100 | |
285 | S100P | |
286 | SALL4 | |
287 | SATB2 | |
288 | SDHB | |
289 | SF-1 | |
290 | Skeletal Myosin | |
291 | SMA | |
292 | SMARCA4/Brg1 | |
293 | Smooth Muscle Myosin | |
294 | SOX10 | |
295 | SOX-11 | |
296 | SOX-2 | |
297 | SOX-9 | |
298 | SSTR2 | |
299 | SSTR5 | |
300 | STAT6 | |
301 | Stathmin | |
302 | SurfactantProteinB | |
303 | Survivin | |
304 | SV40TAg | |
305 | Synaptophysin | |
306 | TCR β F1 | |
307 | TdT | |
308 | TFE3 | |
309 | TG | |
310 | THY | |
311 | ThyroidStimulatingHormone | |
312 | TIA-1 | |
313 | TLE1 | |
314 | TOP2A | |
315 | T-PIT | |
316 | TPO | |
317 | TRIM29 | |
318 | TROP2 | |
319 | TRPS1 | |
320 | TS | |
321 | TTF-1 | |
322 | UroplakinⅡ | |
323 | UroplakinⅢ | |
324 | VEGF | |
325 | Villin | |
326 | Vimentin | |
327 | WT1 | |
328 | β-FSH | |
329 | β-LH | |
330 | β-tubulin-III | |
331 | FGFR2b | |
332 | nectin-4 |
二、需提交的材料:
1、经营企业资质:营业执照、组织机构代码证、税务登记证、医疗器械经营许可证,产品销售授权证明、法人授权委托人证明及被委托人身份证明。
2、生产企业资质:生产企业营业执照和医疗器械生产许可证。
3、产品相关资质:医疗器械注册证/备案证、产品说明书、产品质量保证书、产品质量检测报告、产品彩页、包装规格说明、挂网产品需提供**省医保公共服务平台挂网截图、业绩。
4、附表一Excel版本发送至邮箱(自行下载表格填写,按要求填写不要随意更改顺序及删减项目内容)。
以上资料需提供加盖公章的复印件一份胶****点击查看采购中心)。
三、欢迎符合以上条件的****点击查看采购中心进行沟通。
四、联系方式
1、联系地点:****点击查看****点击查看中心(2号楼发热门诊旁四楼)
2、联系电话:158****点击查看6007
3、邮箱:****点击查看@qq.com
4、联系人:赵心彤
5、自发布公示之日起不少于7个工作日。
****点击查看
2025年8月8日